Literature DB >> 2959512

Metallothionein: a bifunctional chelator for the radiolabeling of biologically active molecules.

M M Morelock1, G L Tolman.   

Abstract

Cysteine-rich metallothionein has been shown to bind as many as seven TcO3+ cores in TcO (Cys) units which adopt square-base pyramidal geometry. The Tc atoms in 99mTc,Zn-MT and 99mTc,Zn-MT-MAb species formed in the exchange reaction with the labile 99mTcO (glucoheptonate) complex are stable to oxidation and transchelation in vivo. The kinetics of labeling with the carrier-free radionuclide 99mTc are diffusion-limited at MT concentrations below 10(-5) M. Zinc-MT-MAb conjugates can be efficiently radiolabeled at concentrations greater than or equal to 10(-5) M. The conjugation of MT to tumor specific MAb's has been accomplished with the preservation of the in vivo tumor targeting capability of the MAb and the excellent metal-binding properties of MT. The success achieved in this research demonstrates the potential of metallothionein as a carrier of medically useful metallic radionuclides in labeling of important biologically active molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959512     DOI: 10.1007/978-3-0348-6784-9_19

Source DB:  PubMed          Journal:  Experientia Suppl        ISSN: 0071-335X


  3 in total

1.  Recombinant antibody-metallothionein: design and evaluation for radioimmunoimaging.

Authors:  C Das; P V Kulkarni; A Constantinescu; P Antich; F R Blattner; P W Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

2.  Metal-binding chimeric antibodies expressed in Escherichia coli.

Authors:  J R Sawyer; P W Tucker; F R Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

3.  Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.

Authors:  J Michael Mathis; Shilpa Bhatia; Alok Khandelwal; Imre Kovesdi; Stephen J Lokitz; Yoshi Odaka; Amol M Takalkar; Tracee Terry; David T Curiel
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.